Fertility and Sterility
Volume 94, Issue 3 , Pages 888-899, August 2010

A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial

Presented at the annual meeting of the American Society of Reproductive Medicine, Washington, D.C., October 14–17, 2007.

  • Richard H. Reindollar, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Dartmouth Medical School and Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
    • Corresponding Author InformationReprint requests: Richard Reindollar, M.D., Department of Obstetrics and Gynecology, Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756 (FAX: 603-650-0906).
    • ,
  • Meredith M. Regan, Sc.D.

      Affiliations

    • Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts
    • ,
  • Peter J. Neumann, Sc.D.

      Affiliations

    • Center for the Evaluation of Value and Risk in Health, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts
    • ,
  • Bat-Sheva Levine, M.D.

      Affiliations

    • Center for the Evaluation of Value and Risk in Health, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts
    • ,
  • Kim L. Thornton, M.D.

      Affiliations

    • Department of Obstetrics, Gynecology and Reproductive Biology, Division of Reproductive Endocrinology and Infertility, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Boston IVF, Waltham, Massachusetts
    • ,
  • Michael M. Alper, M.D.

      Affiliations

    • Department of Obstetrics, Gynecology and Reproductive Biology, Division of Reproductive Endocrinology and Infertility, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Boston IVF, Waltham, Massachusetts
    • ,
  • Marlene B. Goldman, Sc.D.

      Affiliations

    • Departments of Obstetrics and Gynecology and Community and Family Medicine, Dartmouth Medical School and Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire

Received 11 March 2009; received in revised form 7 April 2009; accepted 8 April 2009. published online 16 June 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 R.H.R. reports receiving fellowship training funds and lecture fees from Ferring, Organon, and Serono before 2005. M.M.R. has nothing to disclose. P.J.N. reports receiving grant support from Elan Pharmaceuticals and Johnson & Johnson, receiving consultant fees from Serono and General Electric, and serving on advisory boards for Merck, Schering Plough, and Abbott; B-S.L. reports receiving an educational grant from Novo Nordisk. K.L.T. reports receiving fellowship training support from Ferring, research grant support from Duramed, Organon, and Serono, consulting fees from Organon, and lecture fees from Organon and Serono. M.M.A. reports receiving unrestricted research grants from Serono and Organon, consulting fees from Serono, and lecture fees from Ferring, Organon, and Serono. M.B.G. has nothing to disclose.

 Supported by a grant from the National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland (R01 HD38561). The National Institute of Child Health and Human Development had no role in the design or conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

 Work was performed at the Department of Obstetrics and Gynecology and Reproductive Biology, Division of Reproductive Endocrinology and Infertility, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Boston IVF, Waltham, Massachusetts; and the Department of Obstetrics and Gynecology, Dartmouth Medical School, Hanover, New Hampshire.

PII: S0015-0282(09)00866-8

doi:10.1016/j.fertnstert.2009.04.022

Fertility and Sterility
Volume 94, Issue 3 , Pages 888-899, August 2010

Article Tools

* Image Usage & Resolution